2,465
Views
5
CrossRef citations to date
0
Altmetric
Original Articles

Validity of the Medication Adherence Rating Scale for Adherence to Inhaled Corticosteroids among Older Adults with Asthma or Chronic Obstructive Pulmonary Disease

, , , &
Pages 74-80 | Received 08 Nov 2019, Accepted 03 Jan 2020, Published online: 17 Jan 2020

Figures & data

Table 1. Demographic and clinical characteristics of patients with asthma.

Table 2. Demographic and clinical characteristics of patients with chronic obstructive pulmonary disease.

Table 3. Mean Medication Adherence Report Scale Scores, by adherence as determined by objective measures.

Table 4. Sensitivity and Specificity of the Medication Adherence Report Scale at different threshold values among patients with asthma.

Table 5. Sensitivity and Specificity of the Medication Adherence Report Scale at different threshold values among patients with COPD.

Figure 1. Receiver operating characteristic curve (AUC= 0.687) evaluating the accuracy of the MARS compared with objective monitoring in the asthma cohort. Abbreviations: AUC, area under the curve; MARS, Medication Adherence Report Scale.

Figure 1. Receiver operating characteristic curve (AUC= 0.687) evaluating the accuracy of the MARS compared with objective monitoring in the asthma cohort. Abbreviations: AUC, area under the curve; MARS, Medication Adherence Report Scale.

Figure 2. Receiver operating characteristic curve (AUC= 0.612) evaluating the accuracy of the MARS compared with objective monitoring in the COPD cohort. Abbreviations: AUC, area under the curve; MARS, Medication Adherence Report Scale; COPD, C

Figure 2. Receiver operating characteristic curve (AUC= 0.612) evaluating the accuracy of the MARS compared with objective monitoring in the COPD cohort. Abbreviations: AUC, area under the curve; MARS, Medication Adherence Report Scale; COPD, C

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.